| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President &CEO | See Remarks
2 companies
Shah Gaurav is a CEO at Rocket Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 9 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | RCKTW Rocket Pharmaceuticals, Inc. | CEO | Sell | 5,990 | $3.34 | $19,994.62 | -0.6% | - | - | |
| Nov 18, 2025 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 6,276 | $2.98 | $18,721.31 | -0.8% | +12.6% | - | |
| May 20, 2025 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 2,253 | $6.45 | $14,522.84 | -0.3% | -55.8% | - | |
| May 16, 2025 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 3,621 | $6.53 | $23,637.89 | -0.5% | -53.4% | - | |
| Apr 10, 2025 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Buy | 20,000 | $5.08 | $101,600.00 | +2.6% | -35.2% | -29.4% | |
| Feb 21, 2025 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 16,303 | $10.58 | $172,485.74 | -2.1% | -37.3% | -63.9% | |
| Nov 21, 2024 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 11,091 | $13.05 | $144,781.91 | -1.5% | -14.6% | -77.1% | |
| Aug 16, 2024 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 9,650 | $18.50 | $178,563.60 | -1.3% | -21.9% | -83.9% | |
| May 16, 2024 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sale+OE | 9,790 | $23.35 | $228,596.50 | -1.3% | -22.0% | -72.2% | |
| Feb 16, 2024 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 20,272 | $29.84 | $604,875.94 | -3.5% | -22.0% | -65.1% |